Literature DB >> 3038298

Hepatocellular carcinoma in Chinese males and females. Possible causes for the male predominance.

C L Lai, P B Gregory, P C Wu, A S Lok, K P Wong, M M Ng.   

Abstract

The male-female ratio in 186 hepatocellular carcinoma (HCC) Chinese patients was 5:1. The clinical presentation, biochemical parameters, and histologic findings were the same in both sexes except for a higher proportion of underlying cirrhosis (P = 0.02), and spider naevi (P = 0.04) in the men. There were also more smokers and alcohol drinkers among the men. Over 75% of both sexes were positive for the hepatitis B surface antigen. The possible contributory factors to the predominance of males to females in HCC included: the association with the hepatitis B virus, the higher proportion of male cirrhotics, smoking, and alcohol drinking. The survival probability for both sexes was equally poor; the median survival was 8 weeks for males and 10 weeks for females.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3038298     DOI: 10.1002/1097-0142(19870901)60:5<1107::aid-cncr2820600531>3.0.co;2-o

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  7 in total

Review 1.  Hepatocellular carcinoma. A worldwide problem and the major risk factors.

Authors:  R G Simonetti; C Cammà; F Fiorello; F Politi; G D'Amico; L Pagliaro
Journal:  Dig Dis Sci       Date:  1991-07       Impact factor: 3.199

2.  Differential Proteomic Analysis of Gender-dependent Hepatic Tumorigenesis in Hras12V Transgenic Mice.

Authors:  Zhuona Rong; Tingting Fan; Huiling Li; Juan Li; Kangwei Wang; Xinxin Wang; Jianyi Dong; Jun Chen; Fujin Wang; Jingyu Wang; Aiguo Wang
Journal:  Mol Cell Proteomics       Date:  2017-05-16       Impact factor: 5.911

Review 3.  Unusual presentation of metastatic hepatocellular carcinoma in the nasal septum: a case report and review of the literature.

Authors:  Ching-Wei Chang; Tsang-En Wang; Li-Tzong Chen; Wen-Hsiung Chang; Yi-Shing Leu; Yang-Kai Fan; Yu-Jan Chan
Journal:  Med Oncol       Date:  2007-11-27       Impact factor: 3.064

4.  Gender difference in clinicopathologic features and survival of patients with hepatocellular carcinoma.

Authors:  Pisit Tangkijvanich; Varocha Mahachai; Pongspeera Suwangool; Yong Poovorawan
Journal:  World J Gastroenterol       Date:  2004-06-01       Impact factor: 5.742

5.  Detection of alphafetoprotein-expressing cells in the blood of patients with hepatoma and hepatitis.

Authors:  S Y Jiang; R Y Shyu; M F Huang; H S Tang; T H Young; S R Roffler; Y S Chiou; M Y Yeh
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

Review 6.  Epidemiology of Hepatocellular Carcinoma in the Asia-Pacific Region.

Authors:  Ran Xu Zhu; Wai-Kay Seto; Ching-Lung Lai; Man-Fung Yuen
Journal:  Gut Liver       Date:  2016-05-23       Impact factor: 4.519

7.  Alpha-fetoprotein-L3 and Golgi protein 73 may serve as candidate biomarkers for diagnosing alpha-fetoprotein-negative hepatocellular carcinoma.

Authors:  Zhiguo Zhang; Yanying Zhang; Yeying Wang; Lingling Xu; Wanju Xu
Journal:  Onco Targets Ther       Date:  2015-12-31       Impact factor: 4.147

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.